Azitra (NYSEAMERICAN:AZTR – Get Free Report) is expected to be issuing its Q3 2026 resultson Wednesday, November 11th. Analysts expect Azitra to post earnings of ($0.20) per share for the quarter. Individuals can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, November 12, 2026 at 4:00 PM ET.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported ($1.70) EPS for the quarter, missing analysts’ consensus estimates of ($1.15) by ($0.55). On average, analysts expect Azitra to post ($2.00) EPS for the current fiscal year and ($0.60) EPS for the next fiscal year.
Azitra Stock Performance
Azitra stock opened at $0.84 on Wednesday. The business has a 50 day simple moving average of $1.87 and a 200-day simple moving average of $1.94. Azitra has a 12 month low of $0.52 and a 12 month high of $4.71.
About Azitra
Azitra, Inc is a clinical-stage biotechnology company focused on developing microbiome-based therapies for dermatological conditions. The company combines microbiology, genetic engineering and computational tools to identify and develop targeted treatments intended to address diseases affecting the skin.
Azitra’s platform centers on engineered strains of beneficial skin bacteria and biologic compounds designed to deliver therapeutic proteins or otherwise influence the skin’s local environment.
Further Reading
- Five stocks we like better than Azitra
- High Voltage Returns: Talen Energy Powers the Data Center Rush
- 3 Dividend Increases Above 10%, But Which Offers the Most Income?
- Meta’s $100 Billion AI Financing Plan Has a Catch for Existing Shareholders
- Tower Semiconductor’s Earnings Are Soaring—So Why Is Its Stock Down More Than 50%?
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
